摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-(2-furylmethyl)-N-[3-(1H-imidazol-1-yl)propyl]-5,6-diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

中文名称
——
中文别名
——
英文名称
7-(2-furylmethyl)-N-[3-(1H-imidazol-1-yl)propyl]-5,6-diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine
英文别名
7-(furan-2-ylmethyl)-N-(3-imidazol-1-ylpropyl)-5,6-diphenylpyrrolo[2,3-d]pyrimidin-4-amine
7-(2-furylmethyl)-N-[3-(1H-imidazol-1-yl)propyl]-5,6-diphenyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine化学式
CAS
——
化学式
C29H26N6O
mdl
——
分子量
474.6
InChiKey
YQXZBFZHTWSYND-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5
  • 重原子数:
    36
  • 可旋转键数:
    9
  • 环数:
    6.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    73.7
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • [EN] COMPOUNDS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS<br/>[FR] COMPOSÉS ET MÉTHODE DE PRÉVENTION ET DE TRAITEMENT DES MÉTASTASES TUMORALES ET DE LA TUMORIGENÈSE
    申请人:US HEALTH
    公开号:WO2013090912A1
    公开(公告)日:2013-06-20
    The disclosure provides compounds for reducing the prevalence of the perinucleolar compartment in cells, for example, of formula (I), wherein R1, R2, R3, and R4 are as defined herein, that are useful in treating a disease or disorder associated with increased prevalence of the perinucleolar compartment, such as cancer. Also disclosed is a composition containing a pharmaceutically acceptable carrier and at least one compound embodying the principles of the invention, and a method of treating or preventing cancer in a mammal.
    本公开提供了一种化合物,用于减少细胞中周核质区的普遍性,例如式(I)中定义的R1、R2、R3和R4,这些化合物对于治疗与周核质区增加普遍性相关的疾病或障碍,例如癌症,是有用的。还公开了一种含有药学上可接受载体和至少一种体现本发明原则的化合物的组合物,以及一种在哺乳动物中治疗或预防癌症的方法。
  • Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis
    申请人:The United States of America, as represented by the Secretary, Department of Health and Human Services
    公开号:US10301314B2
    公开(公告)日:2019-05-28
    The disclosure provides compounds for reducing the prevalence of the perinucleolar compartment in cells, for example, of formula (I), wherein R1, R2, R3, and R4 are as defined herein, that are useful in treating a disease or disorder associated with increased prevalence of the perinucleolar compartment, such as cancer. Also disclosed is a composition containing a pharmaceutically acceptable carrier and at least one compound embodying the principles of the invention, and a method of treating or preventing cancer in a mammal.
    本发明公开了用于降低细胞核周室流行率的化合物,例如,式(I)化合物,其中 R1、R2、R3 和 R4 如本文所定义,可用于治疗与细胞核周室流行率增加有关的疾病或紊乱,如癌症。还公开了一种含有药学上可接受的载体和至少一种体现本发明原理的化合物的组合物,以及一种治疗或预防哺乳动物癌症的方法。
  • COMPOUNDS AND METHODS FOR THE PREVENTION AND TREATMENT OF TUMOR METASTASIS AND TUMORIGENESIS
    申请人:The United States of America,as represented by the Secretary, Department of Health and Human Service
    公开号:US20140323438A1
    公开(公告)日:2014-10-30
    The disclosure provides compounds for reducing the prevalence of the perinucleolar compartment in cells, for example, of formula (I), wherein R 1 , R 2 , R 3 , and R 4 are as defined herein, that are useful in treating a disease or disorder associated with increased prevalence of the perinucleolar compartment, such as cancer. Also disclosed is a composition containing a pharmaceutically acceptable carrier and at least one compound embodying the principles of the invention, and a method of treating or preventing cancer in a mammal.
  • US9663521B2
    申请人:——
    公开号:US9663521B2
    公开(公告)日:2017-05-30
  • US9877966B1
    申请人:——
    公开号:US9877966B1
    公开(公告)日:2018-01-30
查看更多